SYRE
#1056
Spyre Therapeutics, Inc. - Common Stock
78.3 5 USD
-0.03%
Precio de mercado
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.61%
Variación mensual
-13.73%
Variación en los últimos 6 meses
+15.65%
Cambio anual
+227.69%
Cierres anteriores
80.4 5
Apertura
80.1 3
Mínimo
78.3 4
Máximo
82.4 5
Indicadores financieros
2022
Current report, 08 Mar 2022
Spyre Therapeutics, Inc. current report, 08 March 2022
8-K
Current report, 09 Feb 2022
Spyre Therapeutics, Inc. current report, 09 February 2022
8-K
Current report, 09 Feb 2022
Spyre Therapeutics, Inc. current report, 09 February 2022
8-K
Current report, 05 Jan 2022
Spyre Therapeutics, Inc. current report, 05 January 2022
8-K
2021
Annual report, FY2021
Spyre Therapeutics, Inc. annual report, FY2021
10-K
Current report, 06 Dec 2021
Spyre Therapeutics, Inc. current report, 06 December 2021
8-K
Current report, 12 Nov 2021
Spyre Therapeutics, Inc. current report, 12 November 2021
8-K
Current report, 04 Nov 2021
Spyre Therapeutics, Inc. current report, 04 November 2021
8-K
Quarterly report, Q3 FY2021
Spyre Therapeutics, Inc. quarterly report, Q3 FY2021
10-Q
Current report, 09 Sep 2021
Spyre Therapeutics, Inc. current report, 09 September 2021
8-K